Product NDC: | 62037-599 |
Proprietary Name: | Cartia |
Non Proprietary Name: | Diltiazem Hydrochloride |
Active Ingredient(s): | 240 mg/1 & nbsp; Diltiazem Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62037-599 |
Labeler Name: | Watson Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074752 |
Marketing Category: | ANDA |
Start Marketing Date: | 19990623 |
Package NDC: | 62037-599-05 |
Package Description: | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62037-599-05) |
NDC Code | 62037-599-05 |
Proprietary Name | Cartia |
Package Description | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62037-599-05) |
Product NDC | 62037-599 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Diltiazem Hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19990623 |
Marketing Category Name | ANDA |
Labeler Name | Watson Pharma, Inc. |
Substance Name | DILTIAZEM HYDROCHLORIDE |
Strength Number | 240 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |